IQVIA (NYSE:IQV) Sees Large Volume Increase – Still a Buy?

Shares of IQVIA Holdings Inc. (NYSE:IQV) saw unusually-high trading volume on Monday . Approximately 872,396 shares changed hands during trading, an increase of 53% from the previous session’s volume of 569,620 shares.The stock last traded at $201.98 and had previously closed at $197.39.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on IQV shares. The Goldman Sachs Group reduced their price objective on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Truist Financial cut their target price on shares of IQVIA from $265.00 to $261.00 and set a “buy” rating on the stock in a research note on Thursday, December 12th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $270.00 price target on shares of IQVIA in a research note on Wednesday, December 11th. Barclays dropped their price target on shares of IQVIA from $260.00 to $255.00 and set an “overweight” rating on the stock in a research note on Friday, November 1st. Finally, TD Cowen decreased their price objective on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $255.82.

IQVIA Stock Up 1.0 %

The company has a market cap of $36.18 billion, a PE ratio of 26.16, a PEG ratio of 2.05 and a beta of 1.48. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The stock’s 50 day moving average price is $202.86 and its 200-day moving average price is $222.14.

Institutional Trading of IQVIA

Institutional investors have recently bought and sold shares of the company. Capital Performance Advisors LLP bought a new stake in shares of IQVIA during the third quarter valued at approximately $27,000. Park Place Capital Corp bought a new stake in shares of IQVIA in the third quarter valued at about $28,000. Itau Unibanco Holding S.A. bought a new stake in shares of IQVIA in the second quarter valued at about $29,000. Avior Wealth Management LLC raised its holdings in IQVIA by 117.6% in the third quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. Finally, Assetmark Inc. raised its holdings in IQVIA by 612.5% in the third quarter. Assetmark Inc. now owns 228 shares of the medical research company’s stock worth $54,000 after purchasing an additional 196 shares in the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.